Search results
Results from the WOW.Com Content Network
Rifaximin, sold under the brand name Xifaxan among others, is a non-absorbable, broad-spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in more than 30 countries for the treatment of a variety of gastrointestinal diseases like ...
When rifaximin is added to lactulose, the combination of the two may be more effective than each component separately. [4] Rifaximin is more expensive than lactulose, but the cost may be offset by fewer hospital admissions for encephalopathy. [19] The antibiotics neomycin and metronidazole are other antibiotics used to treat hepatic ...
The SPARC Innovation Program at the Mayo Clinic in Rochester, Minnesota, is widely recognized as the first design-based research and development laboratory for health services. [8] The brainchild of Drs. Nicholas F. LaRusso, Chair, Department of Medicine, and Michael D. Brennan, Associate Chair, Department of Medicine, the idea of SPARC began ...
Rifaximin is an oral rifamycin marketed in the US by Salix Pharmaceuticals that is poorly absorbed from the intestine. It has been used to treat hepatic encephalopathy and traveler's diarrhea . [ 19 ]
Individualized medicine represents a further individualization of personalized medicine. While the latter is aimed at a specific group of patients, individualized medicine deals with the individual circumstances of a single person. Thus, individualized medicine goes one step further and can be considered as an increase in personalized medicine.
Prevention is typically by avoiding the use of aspirin in children. [1] When aspirin was withdrawn for use in children in the US and UK in the 1980s, a decrease of more than 90% in rates of Reye syndrome was observed. [2] Early diagnosis of the syndrome improves outcomes. [1] Treatment is supportive; [1] mannitol may be used to help with the ...
Chrysalis House does not offer Suboxone, but it does accept mothers who are on the medication — although Stamper said they make up less than 5 percent of the residents. Despite the clinic’s failure rate, she has not considered making the medication more accessible. “I don’t know how to answer that question,” she said.
The Mayo Clinic Cancer Center is one of the oldest NCI-designated cancer centers in the United States, having first been designated in 1973. [3] The main location of the Mayo Clinic is in Rochester, MN. Campuses in Arizona and Florida opened later and became part of the Mayo Clinic Cancer Center in 2003. [4] [5]